Table 2 Characteristics of patients on ART with regard to the occurrence of hyperlactatemia
From: Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon
|  | Normolactatemic n = 74 (Mean ± SD) | Hyperlactatemic n = 17 (Mean ± SD) | p |
|---|---|---|---|
Age (years) | 40.3 ± 9.4 | 39.9 ± 12.2 | 0.865 |
Sex (Male/Female) | 16/58 | 6/11 | 0.189 |
CD4 count at time of hyperlactatemia (cells/mm 3 ) | 414.5 ± 230.8 | 392.8 ± 239.6 | 0.730 |
Duration of cumulative ART exposure prior to hyperlactatemia (years) | 5.2 ± 2.9 | 4.5 ± 3.2 | 0.382 |
ART regimens | Â | Â | Â |
First line | 44 | 16 | 0.007* |
Second line | 30 | 1 | Â |
CDC/WHO Class | Â | Â | Â |
A | 73 | 17 | 0.813 |
C | 1 | 0 | Â |
FPG (g/L) | 0.9 ± 0.1 | 0.9 ± 0.2 | 0.220 |
AST (IU/L) | 26.7 ± 12.0 | 32.8 ± 27.4 | 0.396 |
ALT (IU/L) | 23.1 ± 11.4 | 36.6 ± 41.8 | 0.221 |
LDH (IU/L) | 419.7 ± 107.9 | 534.3 ± 207.0 | 0.040* |
Lactataemia (mmol/L) | 1.8 ± 0.6 | 4.2 ± 1.8 | < 0.001* |